Silas S. Santana

Learn More
The kinetics of the humoral immune response was evaluated using the recombinant SAG2A protein comparatively to soluble Toxoplasma antigen (STAg) by ELISA in sequential serum samples of patients with toxoplasmosis up to 12 months of illness onset. The follow up of IgM and IgA levels to STAg showed a gradual decrease, with the majority of patients (88%)(More)
Infection by Toxoplasma gondii affects around one-third of world population and the treatment for patients presenting toxoplasmosis clinically manifested disease is mainly based by a combination of sulfadiazine, pyrimethamine, and folinic acid. However, this therapeutic protocol is significantly toxic, causing relevant dose-related bone marrow damage. Thus,(More)
No reliable data are available from most Brazilian states for a number of child health indicators, such as nutritional status, breast feeding, vaccine coverage, incidence and management of infectious diseases, and coverage of antenatal and perinatal services. However a methodology has been developed for state-wide, community-based health surveys for the(More)
Between 2007 and 2009, a cross-sectional survey was carried out in Maranhão State, Brazil to estimate the seroprevalence of and risk factors for bovine brucellosis. In total, 749 herds and 6779 cows greater than two years of age were blood sampled. At the time of sampling a questionnaire to collect details on possible risk factors for bovine brucellosis was(More)
Considering that the current immunoassays are not able to distinguish the infective forms that cause Toxoplasma gondii infection, the present study was carried out to evaluate the reactivity of two recombinant proteins (CCp5A and OWP1) from oocyst/sporozoite, in order to differentiate infections occurring by ingestion of oocysts or tissue cysts. The(More)
  • 1